1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow 1PC111: new trials by email Literature Review of 1PC111 trials Research Report on 1PC111
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia Pitavastatin, Ezetimibe, 1PC111 - Primary Hypercholesterolemia, Mixed Dyslipidemias | Phase 3 | Completed | Orient Pharma Co., Ltd. | 390 | 2020-08-01 | 2022-05-18 |
Australia (1) · New Zealand (1) · Taiwan (1)